Supreme Court Declines ‘Skinny Label’ Case, But Teva To Continue Fight In District Court

 
• By Brenda Sandburg

Justice Kavanaugh voted to grant Teva’s petition for certiorari. It is unknown if other justices voted with him. The high court last month declined to hear Novartis's Gilenya patent case and Sanofi’s antitrust allegations against Mylan’s EpiPen rebate agreements.

Supreme Court building
Supreme Court declines to take up three pharma-related cases • Source: Shutterstock

More from Generics

More from Biosimilars & Generics